Advertisement
U.S. markets open in 4 hours 58 minutes
  • S&P Futures

    4,567.00
    -9.50 (-0.21%)
     
  • Dow Futures

    36,234.00
    -34.00 (-0.09%)
     
  • Nasdaq Futures

    15,807.25
    -61.75 (-0.39%)
     
  • Russell 2000 Futures

    1,883.70
    -1.20 (-0.06%)
     
  • Crude Oil

    74.00
    +0.96 (+1.31%)
     
  • Gold

    2,048.60
    +6.40 (+0.31%)
     
  • Silver

    24.85
    -0.06 (-0.23%)
     
  • EUR/USD

    1.0845
    +0.0008 (+0.08%)
     
  • 10-Yr Bond

    4.2880
    0.0000 (0.00%)
     
  • Vix

    13.26
    +0.18 (+1.38%)
     
  • GBP/USD

    1.2633
    +0.0001 (+0.01%)
     
  • USD/JPY

    147.1100
    -0.0470 (-0.03%)
     
  • Bitcoin USD

    41,687.12
    +9.17 (+0.02%)
     
  • CMC Crypto 200

    855.62
    -3.09 (-0.36%)
     
  • FTSE 100

    7,490.53
    -22.43 (-0.30%)
     
  • Nikkei 225

    32,775.82
    -455.45 (-1.37%)
     

Eli Lilly shares dip for second day amid broader market downturn

Eli Lilly&Co (NYSE:LLY). experienced a decrease in share value for the second consecutive day, with a 3.42% drop on Thursday, closing at $550.13. This downturn is part of a broader decline in the stock market, with both the S&P 500 Index and the Dow Jones Industrial Average also witnessing declines of 1.64% and 1.08%, ending at 4,330.00 and 34,070.42 respectively.

The pharmaceutical giant's closing price was $51.71 below its 52-week high of $601.84, achieved on September 14, 2023. In comparison to other companies in the same sector on Thursday, Eli Lilly&Co.'s performance was less impressive. For instance, Johnson&Johnson (NYSE:JNJ) experienced a lesser decline of 0.77%, with its shares closing at $161.66.

In addition to the decline in share value, another significant aspect of Thursday's trading was the volume of shares traded for Eli Lilly&Co., which stood at 4 million, surpassing its 50-day average trading volume of 2.9 million.

The data for this report is derived from information provided by Dow Jones and FactSet, as part of an automated analysis by a technology provider specializing in market data automation.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Related Articles

Eli Lilly shares dip for second day amid broader market downturn

KESM Industries narrows FY23 losses, Kenanga raises target price to RM7.06

Strikes end at Chevron's Australian LNG facilities

Advertisement